Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06451341 · ClinicalTrials.gov registry record

IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas

A clinical trial of HIV, sponsored by University of Nebraska.

Recruiting
Registry status
55
Enrollment target
2
Study locations

NCT06451341 is a study of HIV that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 55 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06451341, a study of HIV, is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
55 participants
Enrollment target
2
Study locations

Study Summary

The goal of this implementation science study is to learn about the experience of receiving and providing cabotegravir + rilpivirine long-acting (CAB+RPV LA) injections as treatment for human immunodeficiency virus (HIV) for people who live a significant distance from an HIV provider. The main questions it aims to answer are: * Is CAB+RPV LA feasible and acceptable to patients and staff? * What barriers and supports exist and have the most impact on receiving and providing CAB+RPV LA? * How does CAB+RPV LA affect HIV stigma, treatment satisfaction, medication adherence and viral suppression? People living with HIV who reside outside of the Omaha, Nebraska metro area and are starting CAB+RPV LA as part of regular medical care for HIV will be invited to participate in this study which involves completing questionnaires and an interview over 15 months. Clinic staff who are involved in providing HIV care and CAB+RPV LA will also provide input through questionnaires and an interview.

Conditions Studied

HIV

Interventions

  • BEHAVIORAL Acceptability of Intervention Measure (AIM)
  • BEHAVIORAL Intervention Appropriateness Measure (IAM)
  • BEHAVIORAL Feasibility of Intervention Measure (FIM)
  • BEHAVIORAL HIV Stigma Scale Questionnaire
  • BEHAVIORAL HIV Treatment Satisfaction Questionnaire status version (HIVTSQs12)

Study Locations (2)

Nebraska

  • Nebraska Medicine Grand Island Clinic - Grand Island
  • University of Nebraska Specialty Care Center - Omaha

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2024-07-01
Est. Completion 2027-04

Sponsor

University of Nebraska

407 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06451341

The ClinicalTrials.gov registry entry for NCT06451341 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (87% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 5 interventions - of which Acceptability of Intervention Measure (AIM) is the first listed.

NCT06451341 reports 2 study locations spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT06451341 about?

NCT06451341 is a clinical study titled "IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas". The goal of this implementation science study is to learn about the experience of receiving and providing cabotegravir + rilpivirine long-acting (CAB+RPV LA) injections as treatment for human immunodeficiency virus (HIV) for people who live a significant distance from an HIV provider. The main quest...

What is the current status of trial NCT06451341?

This trial is currently recruiting. The enrollment target is 55 participants. The study started on 2024-07-01. Estimated completion is 2027-04.

What conditions does trial NCT06451341 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06451341?

The interventions under investigation include: Acceptability of Intervention Measure (AIM) (BEHAVIORAL), Intervention Appropriateness Measure (IAM) (BEHAVIORAL), Feasibility of Intervention Measure (FIM) (BEHAVIORAL), HIV Stigma Scale Questionnaire (BEHAVIORAL), HIV Treatment Satisfaction Questionnaire status version (HIVTSQs12) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06451341?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06451341 being conducted?

This trial has 2 study locations across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.